Suzetrigine: A Newly FDA-Approved Non-Opioid Treatment Option for Management of Moderate to Severe Acute Pain

Authors
Category Systematic review
JournalInnov. Clin. Neurosci.
Year 2026
This article has no abstract
Epistemonikos ID: e4db2bc35e08aa61a0739f1c465e512ee194467d
First added on: Oct 10, 2026